Nordhealth AS (NORDH) — Capital Reinvestment Ratio
Latest as of September 2025:
3.10x
Nordhealth AS (NORDH) has a Capital Reinvestment Ratio of 3.10x as of September 2025, meaning it reinvests 3% of its operating cash flow (Nkr1.22 Million) in capital expenditures (Nkr3.77 Million). See cash generation quality of Nordhealth AS to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
3.10x
Capex / Operating Cash Flow
Operating Cash Flow
Nkr1.22 Million
NOK
Capital Expenditures
Nkr3.77 Million
NOK
Data as of
Sep 2025
Most recent filing
Nordhealth AS Capital Reinvestment Ratio (2018–2025)
This chart tracks Nordhealth AS's Capital Reinvestment Ratio across 6 annual periods.
Annual Capital Reinvestment Ratio for Nordhealth AS (2018–2025)
Year-by-year Capital Reinvestment Ratio for Nordhealth AS from 2018 to 2025. For live market cap and broader valuation context, see NORDH market cap.
| Year | Reinvestment Ratio | Operating CF (NOK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 7.08x | Nkr719.00K | Nkr5.09 Million | ▲ +160.8% |
| 2024 | 2.72x | Nkr1.85 Million | Nkr5.02 Million | ▲ +347.8% |
| 2021 | 0.61x | Nkr5.57 Million | Nkr3.38 Million | ▲ +0.0% |
| 2020 | 0.61x | Nkr5.57 Million | Nkr3.38 Million | ▲ +0.0% |
| 2019 | 0.61x | Nkr5.57 Million | Nkr3.38 Million | ▲ +0.0% |
| 2018 | 0.61x | Nkr5.57 Million | Nkr3.38 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow